Related Experiment Video

Updated: Mar 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.7K

Molecular mechanisms of atrial fibrosis: implications for the clinic

Shivshankar Thanigaimani1, Dennis H Lau1, Thomas Agbaedeng1

  • 1a Centre for Heart Rhythm Disorders , South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital , Adelaide , Australia.

Expert Review of Cardiovascular Therapy
|March 9, 2017
PubMed
Abstract

Insights

Atrial fibrosis drives atrial fibrillation (AF) by disrupting heart rhythm. New treatments targeting fibrosis and aggressive risk factor management are crucial for improving AF outcomes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Fibrosis Research

Background:

  • Atrial fibrillation (AF) is linked to various cardiac conditions and risk factors.
  • Atrial fibrosis is a key structural abnormality causing conduction disturbances that promote AF.
  • Current understanding of molecular mechanisms in atrial fibrosis lacks targeted therapeutic strategies.

Purpose of the Study:

  • To review key molecular signaling pathways involved in atrial fibrosis.
  • To discuss potential therapeutic options for modulating atrial substrate.
  • To examine the role of lifestyle and risk factor management in reversing atrial remodeling.

Main Methods:

  • Literature review of molecular signaling pathways (Angiotensin II, TGF-ß1, CTGF, endothelin-1).
  • Analysis of current and emerging therapeutic strategies for atrial fibrosis.
  • Evaluation of evidence for lifestyle and risk factor modification in AF management.

Main Results:

  • Identified key molecular pathways contributing to atrial fibrosis.
  • Highlighted potential therapeutic targets for anti-fibrotic interventions.
  • Emphasized the importance of integrated care including risk factor management for AF.

Conclusions:

  • An integrated approach combining risk factor management with traditional AF care is essential.
  • Further translational research into molecular therapeutics for atrial fibrosis is urgently needed.
  • Modulating atrial substrate through targeted therapies and lifestyle changes holds promise for improved AF outcomes.
Keywords:
Atrial fibrillationatrial fibrosisatrial remodelingmolecular mechanismsrisk factor management

More Related Videos

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.2K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
697
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
520
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K